PP116. Circulating PlGF can help predict preeclampsia and adverse outcome in patients with suspected preeclampsia or fetal growth restriction

2012 ◽  
Vol 2 (3) ◽  
pp. 302-303 ◽  
Author(s):  
J. Sibiude ◽  
M.-D. Dionne ◽  
J. Guibourdenche ◽  
C. Le Ray ◽  
O. Anselem ◽  
...  
2018 ◽  
Vol 218 (1) ◽  
pp. S297-S298
Author(s):  
Ofer Beharier ◽  
shani Swissa ◽  
Irit Szaingurten-Solodkin ◽  
Asnat Walfisch ◽  
shimrt Yaniv-Salem ◽  
...  

2013 ◽  
Vol 208 (1) ◽  
pp. S171
Author(s):  
Anthony Odibo ◽  
Katherine Goetzinger ◽  
Alison Cahill ◽  
Linda Odibo ◽  
George Macones

2002 ◽  
Vol 13 (4) ◽  
pp. 249-259 ◽  
Author(s):  
Jason Gardosi

With the ascendancy of biophysical assessment with Doppler velocimetry, and the establishment of routine scan dating in early pregnancy, there needs to be a radical re-think of the role of ultrasound biometry in the definition and assessment of fetal growth restriction (FGR).Doppler flow velocimetry of the umbilical artery has proven its value in defining the FGR fetus. It is more useful than cardiotocography (CTG) or biophysical profile scoring. However, the sensitivity of any test depends on the prevalence of the condition being looked for. While Doppler is of value in fetuses which are small-for-gestational age (SGA), it is less useful in predicting growth restriction or adverse outcome in the general population. The question is therefore, how to detect those pregnancies for which further fetal assessment is indicated.


Author(s):  
Bronacha Mylrea-Foley ◽  
Hans Wolf ◽  
Tamara Stampalija ◽  
Christoph Lees ◽  
B. Arabin ◽  
...  

Abstract Purpose To assess the longitudinal variation of the ratio of umbilical and cerebral artery pulsatility index (UCR) in late preterm fetal growth restriction (FGR). Materials and Methods A prospective European multicenter observational study included women with a singleton pregnancy, 32+ 0–36+ 6, at risk of FGR (estimated fetal weight [EFW] or abdominal circumference [AC] < 10th percentile, abnormal arterial Doppler or fall in AC from 20-week scan of > 40 percentile points). The primary outcome was a composite of abnormal condition at birth or major neonatal morbidity. UCR was categorized as normal (< 0.9) or abnormal (≥ 0.9). UCR was assessed by gestational age at measurement interval to delivery, and by individual linear regression coefficient in women with two or more measurements. Results 856 women had 2770 measurements; 696 (81 %) had more than one measurement (median 3 (IQR 2–4). At inclusion, 63 (7 %) a UCR ≥ 0.9. These delivered earlier and had a lower birth weight and higher incidence of adverse outcome (30 % vs. 9 %, relative risk 3.2; 95 %CI 2.1–5.0) than women with a normal UCR at inclusion. Repeated measurements after an abnormal UCR at inclusion were abnormal again in 67 % (95 %CI 55–80), but after a normal UCR the chance of finding an abnormal UCR was 6 % (95 %CI 5–7 %). The risk of composite adverse outcome was similar using the first or subsequent UCR values. Conclusion An abnormal UCR is likely to be abnormal again at a later measurement, while after a normal UCR the chance of an abnormal UCR is 5–7 % when repeated weekly. Repeated measurements do not predict outcome better than the first measurement, most likely due to the most compromised fetuses being delivered after an abnormal UCR.


Sign in / Sign up

Export Citation Format

Share Document